|Published (Last):||3 January 2010|
|PDF File Size:||7.83 Mb|
|ePub File Size:||12.20 Mb|
|Price:||Free* [*Free Regsitration Required]|
Escreva sua busca abaixo:. Uso Oftalm. Uso restrito a hospitais. Join our Staff. Awards and Recognition Eurofarma has some of the most important market recognitions. The commitment and pursuit of innovation guide important milestones in the history of Eurofarma, as the launch of the first generic product for oncological use in Brazil in early and, shortly after, of generic oral and injectable contraceptives, ahead of the competition.
In , the company developed and obtained registration for the first biosimilar medication in Latin America. Eurofarma believes in the broad development and always seeks economic, social and environmental balance.
Water reuse, renewable energy, recycling, citizenship and education are some of the company's commitments. Instituto Eurofarma. Eurofarma Products Eurofarma has a broad portfolio that meets all medical specialties and is a reference in the central nervous system, anti-infective levels and hormonal drugs.
Consumers change profile. Antidepresivos triciclicos. View all products. You are accessing a restricted area. If you are a health professional, complete the information below to access this area. If you are a vet, fill out the information below to access this area.
Sobredosis de antidepresivos tricíclicos
Pero no funcionan inmediatamente. Las personas generalmente tienen un alivio moderado del dolor con antidepresivos. Entre ellos se incluyen los siguientes:. Sin embargo, solo ha mostrado una eficacia limitada para aliviar otros tipos de dolor. La fluoxetina puede causar ciertos efectos secundarios, como insomnio y mareos. Se puede reimprimir una sola copia de estos materiales para usar en forma personal y no comercial.
[Antidepressants in Epilepsy]
Depression is a common condition in patients with epilepsy that entails a deterioration of the quality of life of this population and that, therefore, requires appropriate treatment. The potential risk of antidepressants in relation to the seizure threshold is overestimated by many professionals, and this has an influence when it comes to making the decision to treat them. It sometimes means that the patients do not receive antidepressant drugs. In this regard, the aim of this review is to present the current state of the art in terms of the safety of antidepressants in patients with epilepsy. A search of the medical literature was conducted and, following its analysis, the most significant results are presented.
These manuscripts contain updated topics with a major clinical or conceptual relevance in modern medicine. The journal adheres to the standards of academic research publications in all aspects including peer-review and ethical principles. The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two receding years. CiteScore measures average citations received per document published.